Chlamydia Treatment
For uncomplicated urogenital Chlamydia trachomatis infection, treat with doxycycline 100 mg orally twice daily for 7 days as first-line therapy, or azithromycin 1 g orally as a single dose when adherence to a 7-day regimen cannot be ensured.
Recommended First-Line Regimens
The two primary treatment options are equally effective for curing infection and relieving symptoms 1, 2:
- Doxycycline 100 mg orally twice daily for 7 days
- Azithromycin 1 g orally as a single dose
Choosing Between Doxycycline and Azithromycin
Doxycycline advantages:
- Lower cost
- Longer track record of safety and efficacy
- Preferred by recent European guidelines 3
Azithromycin advantages:
- Single-dose administration ensures complete treatment
- Better for patients with questionable compliance
- Allows directly observed therapy
- May be more cost-effective in populations with erratic healthcare-seeking behavior 2, 4
In clinical practice, choose azithromycin when:
- Patient compliance is uncertain
- Patient unlikely to return for follow-up
- Directly observed therapy is needed
- Otherwise, doxycycline is preferred due to cost and equivalent efficacy
Alternative Regimens
If first-line options cannot be used 2:
- Levofloxacin 500 mg orally once daily for 7 days
- Ofloxacin 300 mg orally twice daily for 7 days
- Erythromycin base 500 mg orally four times daily for 7 days (less effective, more GI side effects)
- Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days
A newer formulation, doxycycline hyclate delayed-release 200 mg once daily for 7 days, demonstrated comparable efficacy to standard doxycycline with less nausea and vomiting, potentially improving adherence 5.
Special Populations
Pregnancy
Doxycycline and fluoroquinolones are contraindicated in pregnancy 1, 2.
Recommended for pregnant women:
- Erythromycin base 500 mg orally four times daily for 7 days
Alternatives if erythromycin not tolerated:
- Erythromycin base 250 mg orally four times daily for 14 days
- Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days
- Erythromycin ethylsuccinate 400 mg orally four times daily for 14 days
- Amoxicillin 500 mg orally three times daily for 7-10 days (if erythromycin cannot be tolerated)
Critical caveat: Erythromycin estolate is contraindicated in pregnancy due to hepatotoxicity risk 1. Repeat testing after treatment is recommended in pregnancy due to limited efficacy data and frequent GI side effects affecting compliance 1.
HIV-Infected Patients
Treat with the same regimens as HIV-negative patients 1, 2, 4.
Adolescents
- Azithromycin safety not established for those ≤15 years 1
- Ofloxacin contraindicated for those ≤17 years 1, 6
- Use doxycycline for adolescents ≥8 years when appropriate
Follow-Up and Partner Management
Test of cure is NOT routinely needed after doxycycline or azithromycin unless 1, 2:
- Symptoms persist
- Reinfection is suspected
- Patient was pregnant (retest recommended)
Retesting considerations:
- Avoid testing <3 weeks post-treatment (risk of false-positive from dead organisms) 1
- Consider rescreening women several months after treatment due to high reinfection rates 1
Partner management:
- Treat all sex partners from the last 30 days (if symptomatic) or 60 days (if asymptomatic) 1
- Treat the most recent partner even if outside these timeframes
- Patients must abstain from sex until both they and partners complete therapy and are symptom-free 2
Important Clinical Considerations
Coinfection with gonorrhea: Given high rates of chlamydia-gonorrhea coinfection, presumptive chlamydia treatment is appropriate when treating gonorrhea, especially if chlamydia testing is unavailable 1.
Why treatment matters: Untreated chlamydia in women can lead to pelvic inflammatory disease, ectopic pregnancy, and infertility 1. Treatment prevents transmission to partners and, in pregnant women, prevents transmission to infants during birth 1.
Common pitfall: Do not use sulfisoxazole—it has inferior efficacy compared to other regimens 1.